Postoperative infections in cytoreductive surgery with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis

Journal of Surgical Oncology

Volumn 96, Issue 6, 2007, Pages 507-513

  Capone, A ^a   Valle, M ^b   Proietti, F ^a   Federici, O ^b   Garofalo, A ^b   Petrosillo, N ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

Candidosis; Perioperative intraperitoneal chemotherapy; Peritonectomy; Postoperative infections

Indexed keywords

CIPROFLOXACIN; CISPLATIN; DOXORUBICIN; FLUCONAZOLE; METICILLIN; METRONIDAZOLE; MITOMYCIN; VANCOMYCIN;

ABDOMINAL SURGERY; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CANCER SURGERY; CANDIDA; CANDIDIASIS; CARCINOMATOUS PERITONITIS; CHEMOSURGERY; CLINICAL ARTICLE; COLON RESECTION; COLORECTAL CANCER; COMBINATION CHEMOTHERAPY; CYTOREDUCTIVE SURGERY; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HYPERTHERMIA; INFECTION RISK; INTESTINE PREPARATION; INTRAOPERATIVE PERIOD; LENGTH OF STAY; MALE; PERITONECTOMY; PERITONEUM CANCER; PERITONEUM MESOTHELIOMA; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEPSIS; SPLENECTOMY; SURGICAL INFECTION; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BACTERIAL INFECTIONS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; PERITONEAL NEOPLASMS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SEPSIS; TREATMENT OUTCOME; WOUND INFECTION;

EID: 35748975154     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20837     Document Type: Article

References (36)

1. Chu DZ, Lang NP, Thompson C, et al.: Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer 1989;63:364-367.
2. Sadeghi B, Arvieux C, Gichen O, et al.: Peritoneal carcinomatosis from non gynecologic malignancies. Results of the EVOCAPE 1 multicentric prospective study. Cancer 2000;88:358-363.
3. Jayne DG, Fook S, Loi C, et al.: Peritoneal carcinomatosis from colorectal cancer. Br J Surg 2002;89:1454-1550.
4. Sugarbaker PH: Peritonectomy procedures. Surg Oncol Clin N Am 2003;12:703-727.
5. Sugarbaker PH: Management of peritoneal surface malignancy using intraperitoneal chemotherapy and cytoreductive surgery: A manual for physicians and nurses, 3rd edition. Grand Rapids, MI: Ludann; 1999.
6. Sugarbaker PH: Peritoneal surface oncology: Review of a personal experience with colorectal and appendiceal malignancy. Tech Coloproctol 2005;9:85-103.
7. Piso P, Bektas H, Werner U, et al.: Improved prognosis following peritonectomy procedures and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from appendiceal carcinoma. Eur J Surg Oncol 2001;27:286-290.
8. Elias D, Blot F, El Otmany A, et al.: Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 2001;92:71-76.
9. Rey Y, Porcheron J, Talabard JN, et al.: Peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemohyperthermia. Ann Chir 2000;125:631-642.
10. Piso P, Dahlke MH, Loss M, et al.: Cytoreductive surgery and hypertermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer. World J Surg Oncol 2004;2:21.
11. Glehen O, Kwiatkowski F, Sugarbaker PH, et al.: Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: A multi-institutional study. J Clin Oncol 2004;22:3284-3292.
12. Sugarbaker PH: Carcinomatosis from gastrointestinal cancer. Ann Med 2004;36:9-22.
13. Sugarbaker PH: New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome. Lancet Oncol 2006;7:69-76.
14. Sugarbaker PH: Laser-mode electrosurgery. In: Sugarbaker PH, editor. Peritoneal carcinomatosis: Principles of management. Boston: Kluwer; 1996; pp. 375-385.
15. Sugarbaker PH, Jablonski KA: Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 1995;221:124-132.
16. Sarnaik AA, Sussman JJ, Ahmad SA, et al.: Technology of intraperitoneal chemotherapy administration: A survey of techniques with a review of morbidity and mortality. Surg Oncol Clin N Am 2003;12:849-863.
17. Alonso O, Sugarbaker PH: Adult respiratory distress syndrome occurring in two patients undergoing cytoreductive surgery plus perioperative intraperitoneal chemotherapy: Case reports and a review of the literature. Am Surg 2000;66:1032-1036.
18. Horsell KW, Merten S, Clingan P, et al.: Peritonectomy and intraperitoneal chemotherapy in appendiceal and colorectal cancer. Aust NZ J Surg 1999;69:729-732.
19. Antoun S, Meshaka P, Soltani D, et al.: Complications and tolerance of heated intraperitoneal chemotherapy and cytoreductive surgery for peritoneal carcinomatosis: Results of a phase I-II study of peritoneal carcinomatosis from different source. Bull Cancer 2000;87:665-670.
20. Chen MY, Chiles C, Loggie BW, et al.: Thoracic complications in patients undergoing intraperitoneal heated chemotherapy with mitomycin following cytoreductive surgery. J Surg Oncol 1997;66:19-23.
21. Esquivel J, Vidal-Jove J, Steves MA, et al.: Morbidity and mortality of cytoreductive surgery and intraperitoneal chemotherapy. Surgery 1993;113:631-636.
22. Francois Y, Grandclement E, Sayag-Beaujard AC, et al.: Intraperitoneal chemo-hyperthermia with mitomycin C in cancer of the stomach with peritoneal carcinosis. J Chir 1997;134:237-242.
23. Verwaal VJ, van Ruth S, de Bree E, et al.: Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003;21:3737-3743.
24. Kusamura S, Younan R, Baratti D, et al.: Cytoreductive surgery followed by intraperitoneal hypertermic perfusion. Cancer 2006;106:1144-1153.
25. Sugarbaker PH, Alderman R, Edwards G, et al.: Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy. Ann Surg Oncol 2006;13:1-10.
26. Stephens AD, Alderman R, Chang D, et al.: Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hypertermic intraoperative chemotherapy using Coliseum technique. Ann Surg Oncol 1999;6:790-796.
27. Sugarbaker PH: Management of peritoneal surface malignancy using intraperitoneal chemotherapy and cytoreductive surgery. A manual for physicians and nurses, 3rd edition. Grand Rapids: Ludann; 1998.
28. Garner JS: CDC guideline for prevention of surgical wound infections, 1985. Supersedes guideline for prevention of surgical wound infections published in 1982 (Originally published in 1985). Revised. Infect Control 1986;7:193-200.
29. Jacquet P, Sugarbaker PH: Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 1996;82:359-374.
30. Garofalo A, Valle M: Staging videolaparoscopy of peritoneal carcinomatosis. Tumori 2003;89:70-77.
31. Valle M, Garofalo A: Laparoscopic staging of peritoneal surface malignancies. Eur J Surg Oncol 2006;32:625-627.
32. Glehen O, Gilly FN: Quantitative prognostic indicators of peritoneal surface malignancy: Carcinomatosis, sarcomatosis, and peritoneal mesothelioma. Surg Oncol Clin N Am 2003;12:649-671.
33. Harmon RL, Sugarbaker PH: Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. Int Semin Surg Oncol 2005;2:3.
34. Gaynes RP, Culcer DH, Horan TC, et al.: Surgical site infection (SSI) rates in the United States, 1992-1998: The National Nosocomial Infections Surveillance System basic SSI Risk Index. Clin Infect Dis 2001;33:S69-S77.
35. Mangram AJ, Horan TC, Pearson ML, et al.: Guideline for prevention of surgical site infection. Am J Infect Control 1999;27:97-132.
36. Pittet D, Monod M, Suter PM, et al.: Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994;220:751-758.